A revival in AstraZeneca Plc shares faces a key test this week, with more likely to hinge on the drugmaker’s ability to ...

An estimated 5,000 people in the United States are living with Eosinophilic Granulomatosis with Polyangiitis (EGPA), a rare ...

Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca (AZ) and development partner Avillion, has been approved by the US Food and Drug Administration (FDA). A first-in-class ...

Researchers in the UK say that AstraZeneca's benralizumab can have a dramatic impact if used to treat acute asthma attacks ... prednisolone alone had a 74% treatment failure rate at 30 days ...

The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...

AstraZeneca Pharma India Ltd. on Thursday said that it has received the permission to import a new drug formulation into India. According to the exchange filing, regulatory authority Central Drugs ...

AstraZeneca AZN will report its fourth-quarter and full-year 2024 earnings on Feb. 6, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $14.28 billion and $1.06 ...

[1] All of these pathophysiologic features are largely represented in asthma, and therefore, anticholinergic drugs have been ... and research activities from: AstraZeneca, Boehringer Ingelheim ...

“At AstraZeneca, we have a bold ambition: to eliminate asthma attacks ... then the goal of treatment is cure,” said Dr. Matunog. “At every stage, patients experience some barriers.

The list of 36 drugs, which are exempt from basic customs duty, includes many expensive and imported medicines that can ...

A small proportion of veterans who went from a metered-dose inhaler to a dry-powder inhaler had to revert to the metered-dose inhaler, according to a research letter published in JAMA Network ...